Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates

INTRODUCTION: The pharmacokinetics of vancomycin are highly variable among neonates, which makes dosing challenging in this population. However, adequate drug exposure is critical, especially when treating methicillin-resistant Staphylococcus aureus (MRSA) infections. Utilization of population pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockmann, Chris, Hersh, Adam L., Roberts, Jessica K., Bhongsatiern, Jiraganya, Korgenski, Ernest K., Spigarelli, Michael G., Sherwin, Catherine M. T., Frymoyer, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471056/
https://www.ncbi.nlm.nih.gov/pubmed/25998107
http://dx.doi.org/10.1007/s40121-015-0067-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471056/
https://www.ncbi.nlm.nih.gov/pubmed/25998107
http://dx.doi.org/10.1007/s40121-015-0067-9

Ejemplares similares